Monday, October 19, 2026
23.2 C
Bengaluru

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its field force—3,000 to 10,000 medical reps in leading companies who crisscross the country daily, building doctor relationships and driving prescriptions. But with the rise of Artificial Intelligence (AI), the ground beneath their feet is beginning to shift.

The question is no longer whether AI will impact field sales—it already is. The real question is: how do we adapt to stay relevant and empowered in this AI-driven era?

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

Anuj Pasrija has been elevated to Country Lead, Johnson...

China’s Biopharma Strategy: A Warning and Opportunity for India

China is playing a long game in biopharma. And...

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

With over two decades of experience across finance, strategy,...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...

Topics

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...

Indian Pharma Is Two Industries Wearing One Label

Indian pharma is often discussed as one sector. In...
spot_img

Related Articles

spot_imgspot_img